Gomm Susanne Ingrid Marianne, Ebner Florian K, Lukac Stefan, El Taie Ziad, Janni Wolfgang, Schmidt-Straßburger Uta, Stoinschek Barbara, Dayan Davut
Alumni Master Online Advanced Oncology, Medical Faculty, University of Ulm, Ulm, Germany.
Department of Gynecology and Obstetrics, University of Ulm, Ulm, Germany.
Geburtshilfe Frauenheilkd. 2022 Sep 13;82(9):941-954. doi: 10.1055/a-1909-8736. eCollection 2022 Sep.
Systematic evaluation of health apps designed to support and aid remote monitoring of patients during breast cancer treatment and aftercare. A systematic search and assessment of apps was conducted using search terms: breast cancer; breast cancer therapy; and breast cancer aftercare. Evaluation criteria were user assessments, scientifically published benefits, user-friendliness, data protection, app individualization, motivation, and financial aspects. Up to two points (P) could be awarded per criterion. The lowest possible score was 0P and the maximum was 28P. Three examiners from different institutions independently assessed the apps according to the specified criteria. Reference value was defined as the average value given by the examiners. Apps with > 18P were classified as "recommended"; ≥ 11-≤ 18P as "partially recommended" and ≤ 10P as "not recommended". A total of 776 apps (n = 24 from the Apple App Store, n = 752 from the Google Play Store) were identified via search query. After applying exclusion criteria, 36 apps (n = 1 from the Apple App Store; n = 35 from the Google Play Store) were evaluated. Using the mean point values of the examiners, 20 apps were classified as not recommended and 12 as partially recommended (≥ 11-≤ 18P). Four apps were rated partially recommended by two examiners and recommended by one examiner. Three apps were rated as recommended by all examiners. Only a small minority of available apps meet recommendation criteria. Use of these apps may benefit breast cancer patients.
对旨在支持和辅助乳腺癌治疗及术后护理期间患者远程监测的健康应用程序进行系统评估。使用搜索词“乳腺癌”“乳腺癌治疗”和“乳腺癌术后护理”对应用程序进行了系统搜索和评估。评估标准包括用户评价、科学发表的益处、用户友好性、数据保护、应用个性化、激励因素和财务方面。每个标准最多可授予两分（P）。最低分数为0P，最高分数为28P。来自不同机构的三名审查员根据指定标准独立评估这些应用程序。参考值定义为审查员给出的平均值。得分>18P的应用程序被归类为“推荐”；得分≥11 - ≤18P的应用程序被归类为“部分推荐”，得分≤10P的应用程序被归类为“不推荐”。通过搜索查询共识别出776个应用程序（苹果应用商店中有24个，谷歌应用商店中有752个）。应用排除标准后，对36个应用程序（苹果应用商店中有1个，谷歌应用商店中有35个）进行了评估。根据审查员的平均得分，20个应用程序被归类为不推荐，12个应用程序被归类为部分推荐（得分≥11 - ≤18P）。有4个应用程序被两名审查员评为部分推荐，一名审查员评为推荐。有3个应用程序被所有审查员评为推荐。只有一小部分可用应用程序符合推荐标准。使用这些应用程序可能会使乳腺癌患者受益。
